Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01060085 · ClinicalTrials.gov registry record
Digital Breast Tomosynthesis Versus Contrast Enhanced Magnetic Resonance Imaging (MRI) for Breast Cancer Staging
A clinical trial of Invasive Breast Cancer and Ductal Carcinoma In Situ, sponsored by Dartmouth-Hitchcock Medical Center.
- Completed
- Registry status
- 51
- Enrollment target
- 1
- Study location
NCT01060085: Completed study of Invasive Breast Cancer and Ductal Carcinoma In Situ, sponsored by Dartmouth-Hitchcock Medical Center.
NCT01060085 is a study of Invasive Breast Cancer and Ductal Carcinoma In Situ that has completed, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 51 participants, below the 130-participant average among 19 other Invasive Breast Cancer trials with a reported enrollment target (61% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01060085, a study of Invasive Breast Cancer and Ductal Carcinoma In Situ, has completed, sponsored by Dartmouth-Hitchcock Medical Center.
- COMPLETED
- Registry status
- 51 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary objective of this study is to compare the diagnostic accuracy of Digital Breast Tomosynthesis (DBT) versus that of Contrast Enhanced Magnetic Resonance Imaging (CEMRI) in determining the size of breast cancer preoperatively. Secondary objectives include: 1. Comparing the operating characteristics of each combined imaging protocol with respect to the reference standard, i.e. histopathologic assessment, of additional non-index lesions. 2. Comparison of re-excision rates based on estimated disease extent from adjunctive CEMRI vs. adjunctive DBT. 3. Evaluation of patient satisfaction with regard to the adjunctive modality (DBT vs. CEMRI).
Conditions Studied
Study Locations (1)
New Hampshire
- Dartmouth-Hitchcock Medical Center - Lebanon
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 51 participants |
| Start Date | 2009-02 |
| Est. Completion | 2016-12-31 |
What the finished NCT01060085 record still lists
NCT01060085 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 51 participants, a relatively small participant target, below the 130-participant average among 19 other Invasive Breast Cancer trials with a reported enrollment target (61% lower).
The record links to 2 conditions, with Invasive Breast Cancer appearing as the primary indexed condition, and to 0 interventions.
NCT01060085 reports a single indexed study location in New Hampshire.
Frequently Asked Questions
What is clinical trial NCT01060085 about?
NCT01060085 is a clinical study titled "Digital Breast Tomosynthesis Versus Contrast Enhanced Magnetic Resonance Imaging (MRI) for Breast Cancer Staging". The primary objective of this study is to compare the diagnostic accuracy of Digital Breast Tomosynthesis (DBT) versus that of Contrast Enhanced Magnetic Resonance Imaging (CEMRI) in determining the size of breast cancer preoperatively. Secondary objectives include: 1. Comparing the operating char...
What is the current status of trial NCT01060085?
This trial is currently completed. The enrollment target is 51 participants. The study started on 2009-02. Estimated completion is 2016-12-31.
What conditions does trial NCT01060085 study?
This clinical trial studies the following conditions: Invasive Breast Cancer, Ductal Carcinoma In Situ.
Who is sponsoring clinical trial NCT01060085?
This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01060085 being conducted?
This trial has 1 study location across New Hampshire. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Invasive Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01060085's enrollment target sits among peer trials
51 15th of 19 higher than 5 of 19 other Invasive Breast Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Invasive Breast Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
CONFIRM: Magnetic Resonance Guided Radiation Therapy
RECRUITING · NA
-
TRUDI: TDXD+Durva in HER2+/Low IBC
RECRUITING · Phase 2
-
A Study of an Alternative Treatment Approach (Preoperative Radiotherapy, Then Mastectomy, Then Immediate Reconstruction Surgery) in People With T4 Breast Cancer
RECRUITING · Phase 1
-
Impact of Vitamin D Supplementation on the Rate of Pathologic Complete Response in Vitamin D Deficient Patients
RECRUITING · Phase 2
-
Tart Cherry Juice as a Dietary Supplement for the Prevention of Paclitaxel-Induced Neuropathy
RECRUITING · Phase 2
-
(Z)-Endoxifen for the Treatment of Premenopausal Women With ER+/HER2- Breast Cancer
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02701153 · 51 participants · NA
Phase II Study of 5-Day Hypofractionated Preoperative Radiation Therapy for Soft Tissue Sarcomas: Expansion Cohort
- NCT03663790 · 51 participants · NA
Effects of Gait Retraining on Lower Extremity Biomechanics
- NCT03874052 · 51 participants · Phase 1
Ruxolitinib in Combination With Venetoclax With and Without Azacitidine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
- NCT04704661 · 51 participants · Phase 1
Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia